LB Pharmaceuticals Inc (LBRX)

LB Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	338	-	-	-
Enterprise Value	327	-	-	-
Debt / Equity Ratio	0.36	0.19	-	-1.12
Quick Ratio	3.64	3.45	16.61	45.64
Current Ratio	3.78	3.56	17.51	45.82
Return on Equity (ROE)	-	-206.22%	-63.14%	-
Return on Assets (ROA)	-	-102.33%	-21.18%	-
Return on Capital (ROIC)	-	-124.86%	-32.30%	-
Buyback Yield / Dilution	-0.87%	-0.87%	-8.02%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q